Cell And Gene Articles, App Notes, Case Studies, & White Papers
-
Stabilization Of RNA-Loaded Lipid Nanoparticles By Lyophilization
8/15/2025
Discover how lyophilization enhances RNA-based therapeutics by enabling storage at higher temperatures, which simplifies cold-chain logistics while preserving nanoparticle integrity and biological activity.
-
End-To-End Workflow Integration For Antibody Development
1/29/2026
Modern antibody discovery generates massive, fragmented datasets that slow collaboration and decision‑making. Examine how unified digital workflows streamline R&D and improve data quality.
-
Business Continuity Management: The Benzonase® Endonuclease Success Story
8/21/2024
Business continuity management is a key success contributor to the pharma industry. Explore best practices for a robust supply chain and how they can translate into success stories.
-
Pre-Launch Checklist - A Roadmap To Success
6/21/2024
The path from groundbreaking therapy to readily available treatment requires a strategic approach. Delve into ten critical questions that can help you chart a successful course for your CGT therapy.
-
Automated PUPSIT For Drug Product Applications
1/13/2026
Automated filtration systems streamline PUPSIT, leak testing, and integrity checks to ensure sterile drug product processing. Learn how these methods improve contamination control and compliance.
-
Automation Of iPSC Culture, Passaging, And Expansion
3/17/2025
Find out how iPSC-derived models enable researchers to generate diverse cell types and tissues as well as how automation reduces the labor-intensive culturing process with AI-powered decision-making.
-
3D Neurospheres In Healthy And Alzheimer's: iPSC-Derived Neurons
4/4/2025
Explore how different ApoE alleles influence Alzheimer's Disease risk using iPSC-derived neurons as well as gain insights into AD mechanisms and potential therapies.
-
Empowering Antibody Discovery With ProSpeed™
11/25/2025
Integrating linear expression technology into single B cell workflows accelerates antibody discovery, enabling early functional screening, improved sensitivity, and cost-effective identification of diverse therapeutic candidates.
-
Unlock 14% Reduction In AAV Gene Therapy Cost Of Goods
3/25/2026
Comparing plasmid DNA to enzymatically produced DNA shows how enzymatic methods cut manufacturing costs, speed production, and boost efficiency for large‑scale AAV gene therapy.
-
Pave The Way To High Productivity With Continuous Manufacturing For Pharma
12/12/2025
Continuous manufacturing delivers agility and precision for pharma, combining automation, reduced manual steps, and quality control to meet regulatory and cost pressures while accelerating development.